Keeren Shah - May 16, 2022 Form 3 Insider Report for OKYO Pharma Ltd (OKYO)

Role
Chief Financial Officer
Signature
/s/ Keeren Shah
Stock symbol
OKYO
Transactions as of
May 16, 2022
Transactions value $
$0
Form type
3
Date filed
5/16/2022, 05:53 PM
Previous filing
Dec 9, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding OKYO Option (right to buy) May 16, 2022 Ordinary Shares 300K $0.20 Direct F1
holding OKYO Option (right to buy) May 16, 2022 Ordinary Shares 500K $0.06 Direct F2
holding OKYO Option (right to buy) May 16, 2022 Ordinary Shares 150K $0.10 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% will vest each year on August 1, beginning on August 2, 2020.
F2 25% will vest each year on August 1, beginning on August 31, 2021.
F3 Vest in equal amounts over three years beginning on January 31, 2022.